Cyanotech (CYAN) Stock Price, News & Analysis

Company Overview

Cyanotech Corporation is a Hawaii-based producer of specialty health and nutrition products derived from microalgae. The company cultivates microalgae in open ponds at its facility on the Kona coast of Hawaii and processes the biomass into nutritional supplements and ingredient products.

Its primary products include Hawaiian Spirulina Pacifica, a spirulina-based nutritional supplement, and BioAstin Hawaiian Astaxanthin, a natural antioxidant derived from the microalga Haematococcus pluvialis. Cyanotech has marketed these products for use in dietary supplements, functional foods and other health-related applications.

Founded in 1983, Cyanotech has served consumer and commercial customers through its own product brands, distributors and ingredient sales channels. Its products have been marketed in the United States and internationally, although the availability of specific products and distribution arrangements may vary by geography.

Key Stats

• Today's Range: $0.55 to $0.59
• 50-Day Range: $0.35 to $0.78
• 52-Week Range: $0.23 to $0.78
• Volume: 8,281 shs
• Average Volume: 6,514 shs
• Market Capitalization: $4.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Cyanotech Stock Analysis - MarketRank™

Cyanotech scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cyanotech.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cyanotech is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cyanotech is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cyanotech has a P/B Ratio of 0.57. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.05% of the float of Cyanotech has been sold short.

Short Interest Ratio / Days to Cover

Cyanotech has a short interest ratio ("days to cover") of 0.84, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cyanotech has recently increased by 135.46%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cyanotech does not currently pay a dividend.

Dividend Growth

Cyanotech does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -1.15

News Sentiment

Cyanotech has a news sentiment score of -1.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Cyanotech this week, compared to 0 articles on an average week.

MarketBeat Follows

1 people have added Cyanotech to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cyanotech insiders have not sold or bought any company stock.

Percentage Held by Insiders

34.40% of the stock of Cyanotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

24.40% of the stock of Cyanotech is held by institutions.

Company Calendar

• Last Earnings: 11/10/2026
• Today: 11/15/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CYAN
• CIK: 768408
• Web: www.cyanotech.com
• Phone: (808) 326-1353
• Fax: 808-329-4533
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.25)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.28 million
• Net Margins: 2.92%
• Pretax Margin: -0.23%
• Return on Equity: 10.54%
• Return on Assets: 3.69%

Debt

• Debt-to-Equity Ratio: 0.13
• Current Ratio: 1.06
• Quick Ratio: 0.39

Sales & Book Value

• Annual Sales: $26.59 million
• Price / Sales: 0.17
• Cash Flow: $0.08 per share
• Price / Cash Flow: 7.34
• Book Value: $1.04 per share
• Price / Book: 0.57

Miscellaneous

• Outstanding Shares: 7,670,000
• Free Float: 5,032,000
• Market Cap: $4.53 million
• Optionable: Not Optionable
• Beta: -0.09